Market cap
₹186 Cr
Revenue (TTM)
₹383 Cr
P/E Ratio
27.2
P/B Ratio
2.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹7 Cr
-
ROE
12.9 %
-
ROCE
13.5 %
-
Industry P/E
21.28
-
EV/EBITDA
19
-
Debt to Equity
0
-
Book Value
₹2
-
EPS
₹0.2
-
Face value
1
-
Shares outstanding
375,372,000
10 Years Aggregate
CFO
₹-12.12 Cr
EBITDA
₹102.21 Cr
Net Profit
₹57.71 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
MK Proteins
| -18.6 | -3.5 | -1.4 | -41.5 | -35.8 | 41.1 | -- |
|
BSE FMCG
| -8.8 | -2.3 | 3.6 | -8.8 | -0.7 | 6.4 | 8.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
MK Proteins
| -25.5 | -66.1 | 12.6 | 1,750.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
MK Proteins
|
4.9 | 185.8 | 382.9 | 6.8 | 2.9 | 9.1 | 27.2 | 2.4 |
| 37.4 | 1,104.5 | 2,903.8 | 126.4 | 6.6 | 13 | 9.6 | 1.2 | |
| 1,778.2 | 4,976.5 | 2,234.3 | 224.7 | 16.6 | 10.7 | 22.3 | 2.4 | |
| 228.4 | 6,738.3 | 24,077.0 | 370.1 | 2.6 | 28 | 18.2 | 4.7 | |
| 42.5 | 419.6 | 4,120.5 | 18.5 | 0.6 | 5.2 | 22.7 | 1.2 | |
| 149.1 | 279.0 | 9.9 | 0.2 | -- | -- | 1234.6 | 13.8 | |
| 82.4 | 411.6 | 921.5 | 33.8 | 4.1 | 14.8 | 12.1 | 1.8 | |
| 16.4 | 540.1 | 3,384.5 | 45.2 | 1.7 | 14.9 | 11.9 | 2.2 | |
| 415.3 | 557.1 | 719.2 | 50.3 | 9.1 | 29.7 | 11.1 | 3.2 | |
| 59.5 | 287.5 | 110.6 | -4.5 | -0.9 | -0.5 | -- | 1.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About MK Proteins
M. K. Proteins Limited engages in the manufactures and trades in vegetable refined oil and by-products in India. It offers rice bran, sunflower, cotton seed, soya bean, palm, canola, and rice bran bleached oils. The company also provides by-products,... including rice bran fatty acid oils, rice bran waxes, gums, and spent earth; imports, processes, and sells crude oils; and trades in edible and non-edible oils. M. K. Proteins Limited was incorporated in 2012 and is based in Ambala, India. Read more
-
Incorporated
2012
-
Chairman
Parvind Kumar
-
Managing Director
Parmod Kumar
-
Headquarters
Ambala, Haryana
-
Website
Looking for more details about MK Proteins Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
FAQs for MK Proteins
What is the current share price of MK Proteins Ltd Today?
The share price of MK Proteins Ltd is ₹4.94 (NSE) and ₹4.95 (BSE) as of 17-Jun-2026 IST. MK Proteins Ltd has given a return of -35.84% in the last 3 years.
What is the current PB & PE ratio of MK Proteins Ltd?
The P/E ratio of MK Proteins Ltd is 27.20 times as on 17-Jun-2026, a 28 premium to its peers’ median range of 21.28 times.
The P/B ratio of MK Proteins Ltd is 2.44 times as on 17-Jun-2026, a 13 premium to its peers’ median range of 2.16 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
27.00
|
3.26
|
|
2024
|
33.08
|
6.07
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.09
|
2.02
|
|
2021
|
0.04
|
1.13
|
What is the 52 Week High and Low of MK Proteins Ltd?
The 52-week high and low of MK Proteins Ltd are Rs 9.78 and Rs 3.56 as of 17-Jun-2026.
What is the market cap of MK Proteins Ltd?
MK Proteins Ltd has a market capitalisation of ₹ 186 Cr as on 17-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in MK Proteins Ltd?
Before investing in MK Proteins Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.